Latest Period
Q4 2025
Security Snapshot
Aptevo Therapeutics Inc. - Common Stock, $0.001 par value per share (APVO) Institutional Ownership
CUSIP: 03835L702
13F Institutional Holders and Ownership History for Q4 2025
Institutions Reporting
10
Shares (Excl. Options)
20,293
Price
$9.43
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- APVO on Nasdaq
- Shares outstanding
- 1,022,610
- Price per share
- $4.57
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 20,293
- Total reported value
- $191,356
- % of total 13F portfolios
- 0%
- Share change
- +20,293
- Value change
- +$191,356
- Number of holders
- 10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 03835L702.
- 10 institutions reported positions in Q4 2025.
- 1 significant owner is listed from Schedule 13D/13G reporting.
What Changed
- Latest quarter on this page is Q4 2025.
- Additional quarter-over-quarter change detail appears as history expands.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 03835L702?
CUSIP 03835L702 identifies APVO - Aptevo Therapeutics Inc. - Common Stock, $0.001 par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03835L702:
Significant Owners of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value per share (APVO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 8.2% | $744,624 | 83,854 | CVI Investments, Inc. | 31 Dec 2025 |
As of 31 Dec 2025, 10 institutional investors reported holding 20,293 shares of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value per share (APVO). This represents 2% of the company’s total 1,022,610 outstanding shares.
Institutional Holders of Aptevo Therapeutics Inc. - Common Stock, $0.001 par value per share (APVO) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 20,293 | $191,356 | +$191,356 | $9.43 | 10 |